Research Article
The Use of START/STOPP Criteria for Elderly Patients in Primary Care
Table 1
Number and percentage of drug inappropriateness according to STOPP criteria.
| Drug inappropriateness | (no.) | % (perc.) |
| Therapeutic (NSAID) duplication | 31 | 64.6 | Use of acetylsalicylic acid at dose >150 mg per day | 9 | 18.8 | Therapeutic (NSAID) duplication and acetylsalicylic acid at dose >150 mg per day | 2 | 4.2 | Use of NSAID in heart failure and therapeutic (NSAID) duplication | 1 | 2.1 | Aspirin and warfarin combination without H2 receptor blocker or proton pump inhibitor (PPI) and use of acetylsalicylic acid at dose >150 mg per day | 1 | 2.1 | Aspirin and warfarin combination without H2 receptor blocker or proton pump inhibitor | 1 | 2.1 | Use of warfarin in combination with NSAID (increased risk for gastrointestinal bleeding) | 1 | 2.1 | Use of calcium channel blocker in chronic constipation | 1 | 2.1 | Use of beta2 agonist or anticholinergic for mild-mediate chronic obstructive pulmonary disease (COPD) or asthma | 1 | 2.1 |
| Total | 48 | 100.0 |
|
|